Lord Kakkar
The Rt Hon. the Lord Kakkar KG KBE
Life peer
Registered Interests (11)
Scientific Adviser, ALJ Health (global distributor of healthcare innovations) (interest ceased 30 April 2025)
Registered: 5 Nov 2021
President, Thrombosis Research Institute
Registered: 2 Oct 2021
Chairman, King's Health Partners (Guy’s and St Thomas’s NHS Foundation Trust)
Registered: 2 Sept 2021
Director, Cyte Ltd (clinical research)
Registered: 12 Sept 2019
Non-executive director, Howard de Walden Estate and Howard de Walden Holdings
Registered: 2 Mar 2018
Non-executive Director, Howard de Walden Estate and Howard de Walden Holdings
Registered: 2 Mar 2018
Research and other assistance is provided by an employee of the Thrombosis Research Institute
Registered: 7 Mar 2011
Some research and other assistance is provided by an employee of the Thrombosis Research Institute
Registered: 7 Mar 2011
Scientific adviser/honoraria in the field of thrombosis research to Anthos Therapeutics (interest ceased 26 August 2025) and VarmX (interest ceased 18 September 2025)
Registered: 27 Apr 2010
Practising clinician (interest ceased 10 April 2025)
Registered: 27 Apr 2010
Scientific Adviser/honoraria in the field of thrombosis research to Bayer Healthcare (interest ceased 31 January 2025), Sanofi (interest ceased 31 January 2025), Anthos Therapeutics (interest ceased 26 August 2025) and VarmX (interest ceased 18 September 2025)
Registered: 27 Apr 2010
Source: UK Parliament API (Open Parliament Licence v3.0). See the official register record for Lord Kakkar ↗.
Get new data by email
A short email when we publish new data or analysis on UK public money, about once a month. Unsubscribe at any time.
We use your email only to send this newsletter and you must confirm it first. See our privacy policy.